Biotech Startups
10,023 companies tagged Biotech, with their investors and founders.
0 investors
NeuroInitiative is a computational biology company that uses a patented AI simulation platform to model neural molecular interactions and prioritize drug targets across aging biology and neurodegeneration. Its platform produced Vincere Biosciences' VB-23, a USP30 inhibitor Parkinson's disease therapy entering Phase 1 clinical trials in 2026.
0 investors
0 investors
Neurolutions makes IpsiHand, an FDA-cleared brain-computer interface system for at-home motor rehabilitation of chronic stroke survivors with arm and hand weakness. The system pairs a non-invasive EEG headset, a thought-controlled wireless handpiece, and a tablet to guide and track therapy.
0 investors
NeuroNascent develops therapeutics aimed at generating new neurons and regenerating existing ones to treat neurological disorders. Its R&D pipeline targets conditions including Alzheimer's disease, Parkinson's disease, and developmental delay, alongside a veterinary medicine program.
0 investors
NMTC develops neurotechnology combining medical devices and artificial intelligence, supported by scientific and AI advisory boards. The company works with medical and neuroscience experts to advance its innovations.
0 investors
0 investors
Neuropathix is a biopharmaceutical company developing patented cannabinoid-inspired molecules and therapeutics targeting inflammation for conditions including chemotherapy-induced peripheral neuropathy, hepatic encephalopathy, mild traumatic brain injury, and chronic pain. Its subsidiary Kannalife Sciences has licensed a U.S. government patent on cannabinoids as antioxidants and neuroprotectants, and its lead drug candidate KLS-13019 is a CBD-like new chemical entity.
0 investors
0 investors
NeuroPro is developing NPT 2042, a drug candidate targeting epilepsy, with reported efficacy in pharmacology models comparable to NKCC antagonists such as bumetanide and furosemide. The compound has shown plasma exposure across species including humans and no negative safety signals in animals or humans to date.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
NeuroVision develops diagnostic tools and a telehealth care-delivery platform for earlier detection and longitudinal monitoring of neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS. Its products include the BrainHealth Clinic cognitive care telehealth platform, Afina AI-based retinal imaging, and the Duritect diagnostics platform, connecting biomarker testing and teleneurology access with clinical workflows.
0 investors
0 investors
0 investors
0 investors
0 investors
New Frontier Bio is a biotechnology company with a cross-functional management team experienced in start-ups, science, strategy, and M&A across healthcare, biotechnology, and cosmetics.
0 investors
0 investors
New Vital Signs is developing a wearable monitoring platform that measures a new generation of precision vital signs to detect physiologic changes earlier than traditional monitors, aimed at identifying at-risk patients (e.g. sepsis, trauma, heart failure, traumatic brain injury). Its products include DRIVE (respiratory/circulating volume), TOBI (cerebral autoregulation), and VATMOS (peripheral vascular tone), developed in partnership with the University of Michigan Center for Integrative Research in Critical Care.</parameter> <parameter name="founders">[]
0 investors